Midwives’ Knowledge and Readiness to Practice Antenatal Screening and Genetic Testing in selected Hospitals in Lagos, Nigeria

Document Type : Original Research Article

Authors

1 Assistant Professor, Department of Nursing, Kulliyyah of Nursing, International Islamic University, Malaysia

2 Senior Lecturer, Department of Nursing, College of Medicine, University of Ibadan, Nigeria

3 Statistician, Department of Total Quality Management, University College Hospital, Ibadan, Nigeria

Abstract

Background & aim: The burden of congenital malformation can be decreased through two major approaches- primary prevention of those at risk through antenatal screening and improving survival for those affected. This study was conducted to investigate the knowledge and readiness of midwives to practice antenatal screening and genetic testing for congenital abnormalities.
Methods: A cross-sectional study among randomly selected 245 midwives across five maternal and child health government hospitals within Lagos metropolis in 2017. The validated self-administered questionnaire having 3-section; midwife’s demographic-characteristics, knowledge and readiness of antenatal screening and genetic testing, with 0.74 reliability coefficient, was used to obtain information within five weeks after obtaining ethical approval. The obtained information was analysed using SPSS version 22.
Results: The study findings revealed that 62.9% of the midwives had inadequate knowledge of antenatal screening and genetic testing for congenital abnormalities. Up to 82.4% were ready to practice antenatal screening and genetic testing for congenital abnormalities. The midwives’ level of knowledge was not significantly associated with their readiness to practice antenatal screening and genetic testing for congenital abnormalities (p=0.74), meanwhile, professional qualification (p = 0.003) and years of experience (p < 0.001) were significantly associated with readiness to practice antenatal screening and genetic testing.
Conclusion: The study recommends that midwives should improve their knowledge and skills in genetic testing by attending both local and international training workshops/seminars. Midwives should be provided with the screening devices to facilitate the practice of antenatal screening and genetic testing for congenital abnormalities.

Keywords


Introduction

Antenatal screening, particularly for a genetic testing is virtually non-existent in Nigeria and the need cannot be overestimated as many congenital abnormalities can lead to long-term devastating consequences and loss of life.

Globally, an approximate of 295,000 newborns dies within 28 days of birth every year, due to congenital anomalies. And such incidence can contribute to long-term disability, which may have significant impacts on individuals, families, health-care systems, and societies at large (1). However, there are also those who develop severe defects while the foetus is still in utero. These defects and deficiencies could have been caused by a number of reasons. According to Helwick (2) a lot of these defects and deficiencies are serious and could lead to severe mental or physical abnormalities. However, if the parents and the health care professionals especially midwives were aware of the problems that the foetus may be facing, they may be more prepared to deal with such abnormalities and be prepared to deal with such situations or conditions after delivery (2). According to World Health Organization (WHO) (3) congenital malformations have been reported to be a major cause of mortality and morbidity in children across the globe. The case fatality rate for most severe abnormalities such as anencephaly, trisomy 13 and trisomy 18 and severe heart defects are virtually 100% by the child first birthday. About 3 – 4 percent of all babies born in the United States have congenital abnormalities that will affect the way they look, develop, or function – in some cases for the rest of their lives (3). In Nigeria, specifically South-eastern part, 2.2% of 5010 infants were presented with congenital anomalies where major anomalies were noted in 93.5% (101/108) infants (4). The varying pattern and prevalence of congenital malformations over time or geographical location may reflect differing methods of detection and frequency due to the complex interaction of known and unknown genetic and environmental factors including socio-cultural, racial, and ethnic variables (5).

The burden of congenital malformation is ancient but not inevitable, it lies on the shoulder of professionals- Surgeons, Clinicians, Epidemiologists, Researchers and especially Midwives -working to improve the outcome and lessen the impacts of congenital defects in the population from an epidemiologic and population-based perspective, which is the focus of this contribution, the burden of congenital malformation can be decreased through two major approaches- primary prevention among those at risk through antenatal screening and improve survival among those who are affected (6). Parents of children with congenital malformation face many problems including multiple surgical intervention, long neonatal hospitalization and often uncertainty about future quality of life (7). The majority of families cope with the situation relatively well and are able to continue their life normally, however coping with a physically or intellectually disabled child is a highly individualized process, and there is evidence to suggest that some families may never adjust fully to this event (8). Considering the importance of knowledge, availability of genetic testing and readiness of midwives to prevent congenital abnormality, we aimed at investigating the knowledge and readiness of midwives to practice antenatal screening and genetic testing for congenital abnormalities in selected hospitals in Lagos State, Nigeria.

Materials and Methods

A descriptive cross sectional survey conducted among midwives in government hospitals in Lagos State built mainly for maternal and child care. Two-stage sampling was applied. Five hospitals were purposively selected; (1) Lagos Island Maternity Hospital (MCC) from Zone A; this is the first state owned maternity built during the colonial era and it is located in the heart of Lagos Island, (2) General Hospital Ikorodu (MCC) from Zone B; the hospital is located at Otunba Benson Road, Ijede Ikorodu, founded in 1983, (3) General Hospital Isolo (MCC) from Zone C; the hospital is located at 120, Mushin Road Isolo in Isolo Local Government Area (4) General Hospital Ifako-Ijaiye (MCC) from Zone D; the hospital is located at 14 College Road, Iju Ifako - Ijaye, (5) General Hospital, Ajegunle (MCC) from Zone E; the hospital is located at 6, Cardoso Street Ajeromi- Ifelodun. Using Yemane formulae for sample size determination, for a total number of 631 midwives and 5% margin of error, a sample of 245 midwives was selected utilizing simple random sampling method to select midwives in each purposively selected hospital with MCC who met the inclusion criteria such as having midwifery qualification, season experienced and reported for duty.

Data collection tool was a structured self-administered questionnaire developed from reviewed literature. Part I: covered midwives’ demographic data (8-items), such as age, professional qualification, year of experience, marital status, current professional status/cadre. Part II: this part was designed to assess midwives’ knowledge of antenatal screening of congenital abnormality (21-items), Part III: covered midwives’ readiness to practice antenatal screening for genetic testing (6-items) and Part IV: this part sought available methods on antenatal screening for congenital abnormality (25-items). With the assistance of the experienced midwives, other researchers and Maternal and child Health experts as well as nursing and pregnant women was sought when developing the questionnaire for the clarity of items, contents for comprehensibility, appropriateness of language and sensibility of questions to ensure the validity of the instrument. After the reviewing of the questionnaire by experts, a pilot study was carried out on 40 midwives who were randomly selected in Orile-Agege General Hospital, for test- retest method within the interval of 2-week, the Pearson correlation was 0.74 to ascertain the reliability of the instrument.

The ethical approval for the study was obtained from the ethical review committee of Lagos State University Teaching Hospital, Lagos. Official permission to administer the questionnaire on midwives at selected secondary health institutions in Lagos State was obtained from the Health Service Commission with reference number HSC/ DNS/ 364/ VOL. II/89. Informed consent was obtained from midwives themselves who were active participants. They were assured of absolute confidentiality of all information supplied and no identifier was permitted. Four 2nd year students from School of Midwifery, Igando, Lagos were recruited as research assistants. They were co-opted and trained on how to assign, allocate and fill the questionnaires to facilitate data collection for period of two days at their school conference hall. The shifting nature of nursing job was taken into consideration when distributing the questionnaires. Each of the Maternal and Child Centres was visited during the shift from 10am-6pm in order to cover the two shifts. The prepared questionnaires were distributed to midwives on duty who have indicated willingness to participate in the study. The questionnaires were collected immediately from the respondents while the contact mobile numbers of those who indicated willingness to return at a later day were obtained, they were followed up and all the questionnaires were retrieved. After data collection, knowledge of midwives was assessed with 21 questions and their scores recorded. A cut off point was set at mean score (12.1). Midwives with the score equivalent to mean score and above were regarded as having adequate knowledge and those with score below mean score as having inadequate knowledge of antenatal screening. Midwives’ readiness to practice genetic testing during antenatal was assessed with two questions and categorized as ‘ready’ and not ‘ready’ while 25 questions were used to determine available screening methods for congenital abnormality. Descriptive statistics on SPSS version 22 was used to present the available screening methods across the selected hospitals.

Results

A total of 540 subjects participated in this study, 270 of whom were female and the rest were male. The mean ages of the employed women and their hu the results reveal that most of the midwives sampled (37.6%) were aged between 31 and 40years and the mean age was 41.1 ± 9.9.

There were more females (96.7%) than males, indicating that there were fewer male midwives in the country. Most (80.0%) practiced Christianity and 85.7% were married. Many (56.3%) of the respondents were Registered Nurses/Registered Midwives only while Registered Midwives only made up 9.0%. The highest category of year of experience was 6 to 10years with 32.7%. In the distribution of cadre, there were more Senior Nursing Officer (24.1%) among the respondents while Assistant Chief Nursing Officer was the least with 8.6% (Table 1).

About half of midwives had practical training in antenatal screening method (55.1%) of which they had correct understanding of antenatal screening, about 9 in ten said that the first step in any screening is counselling, 43.7% knew that the two types of antenatal screening were Invasive and Non-invasive, 53.9% of the respondents said that ultrasonography is usually done in first trimester, 72.2% said that there is no negative implication of antenatal test, 65.7% agreed that the best time to have amniocentesis done is first or second trimester, 85.7% agreed that antenatal screening is used to categorise pregnancy in high and low risk group for various condition, the respondents agreed that the conditions that can be screened for during antenatal were Rh factor, Anaemia and Amniocentesis with 58.4%, 31.0% and 10.6% respectively (Table 2a).

Approximately half (55.5%) had correct understanding of congenital abnormality as a true defects that have a genetic component, 64.9% understand that congenital abnormality occurs as a result of defect in chromosome, 91.4% agreed that Down syndrome is one of the congenital abnormality, 79.6%  agreed that Down syndrome is trisomy 21, 85.3% agreed that Amniocentesis is also referred to as

amniotic fluid test, 66.1% agreed that the best time to have amniocentesis done is 16 – 22weeks of conceived, 82.9% agreed that genetic testing is also known as DNA testing, 46.1% said that New-born screening testing is the type of genetic testing they know and 62.9% agreed that blood and mucus is sample used for genetic testing (Table 2b).

62.9% of the midwives had insufficient knowledge of Genetic Testing for Congenital abnormality (Figure 1).

The result showed that 48.2% of midwives prepared for the practice in terms of using the available screening equipment, 82.4% were willing to offer antenatal screening to pregnant mothers, and 83.3% encouraged pregnant mothers to go for antenatal screening (Table 3).

82.4% of the midwives reported their readiness to practice genetic testing (Figure 2).

Under non-invasive techniques, response to foetal visualization comprises of ultrasound 94.3%, foetal echocardiography 60.0%, Magnetic Resonance Imaging (MRI) 43.3%, Radiography 64.9%, Screening for neural tube defects (NTDs) 33.9% and Measurement of maternal serum alpha-fetoprotein (MSAFP) 29.8%. The response to screen for foetal down syndrome comprises of 24.9% MSAFP, 32.3% maternal unconjugated estriol, 38.4% maternal serum beta-human chorionic gonadotropin (HCG), 30.2% inhibin, 23.7% separation of foetal cells from the mother’s blood and 24.5% assessing foetal-specific DNA methylation ratio (Table 4).

Invasive technique, the response to embryoscopy was 53.9% and fetoscopy 54.3%. Fetal visualization comprises of Amniocentesis 50.6%, chorionic villus sampling (CVS) 47.3%, percutaneous umbilical blood sampling (PUBS) 32.7%, percutaneous skin biopsy 21.6% and pre-implementation biopsy blastocysts obtained by in vitro fertilization 19.6%.

 For cytogenetic investigations, 20.4% had detecting chromosomal aberrations, 18.0% had fluorescent in situ hybridization, 14.3% had molecular genetic techniques, 11.4% had linkage analysis using microsatellite markers, 13.9% had restriction fragment length polymorphisms (RFLPs) and 13.9% single nucleotide polymorphisms (SNPs) – DNA chip, dynamic allele-specific hybridization (DASH) (Table 5).

 

It was revealed that the result of the association between the midwives readiness to practice antenatal screening and genetic testing was not significantly associated with their level of knowledge (p = 0.74) meanwhile, professional qualification (p = 0.003) and years of experience (p < 0.001) were significantly associated with readiness to practice antenatal screening and genetic testing. Therefore, level of knowledge of antenatal screening and genetic testing among the midwives has no significant influence on their readiness to practice antenatal screening and genetic testing in their various health facilities but professional qualification and years of experience were significantly associated with readiness to practice antenatal screening and genetic testing for pregnant woman (Table 6).

Discussion

The findings revealed that less than half of the midwives had adequate knowledge of antenatal screening whereas more than half had practical training in antenatal screening methods this could be as a result of infrequent practice of the method and unavailability of devices required for its practice. The finding correlates with Edward and Msemo (9) who reported inadequate knowledge on the part of midwives as regards antenatal screening for congenital abnormality. That is, generally, the midwives in Nigeria have not been able to develop more understanding of antenatal screening for congenital abnormality.

The study revealed that majority of the midwives were ready to practice genetic screening for the pregnant women and as part of their readiness, majority were willing to offer antenatal screening and encouraged pregnant mothers to go for antenatal screening. Also, the study showed that despite their readiness, only few of the health facilities possess the necessary equipment for the screening for abnormality. This is similar to Martin et al; Lea and Heather; Lawson et al who reported that midwives’ focus on giving information may inhibit them in daily practice from establishing a real dialogue during antenatal screening and as primary maternity care providers, midwives should offer the current antenatal screening options to all women through informed choice discussions. In addition, the study in United State reported that fetal aneuploidy screening was offered to all patients and this was done for the detection of Down syndrome, also majority offer NIPT as a first-line screening method for the risk assessment of trisomy 21, rather than serum-based traditional screening such as quad or first trimester screening (10),(11),(12),(13).

The study findings revealed that under non-invasive techniques, ultrasound, fetal echocardiography and radiography were the majorly available screening techniques while screening for neural tube defects (NTDs), measurement of maternal serum alpha-fetoprotein (MSAFP), measurement of  maternal unconjugated estriol, measurement maternal serum beta-human chorionic gonadotropin (HCG), measuring inhibin, separation of fetal from mother’s blood and assessing fetal specific DNA methylation ratio on down syndrome were less available.

In invasive technique, the following were averagely available, embryoscopy, fetoscopy, Amniocentesis and chorionic villus sampling while percutaneous umbilical blood sampling (PUBS), percutaneous skin biopsy, pre-implementation biopsy blastocysts obtained by in vitro fertilization, detecting chromosomal aberrations, fluorescent in situ hybridization, molecular genetic techniques, linkage analysis using microsatellite markers, restriction fragment length polymorphisms (RFLPs) and single nucleotide polymorphisms (SNPs) – DNA chip, dynamic allele-specific hybridization (DASH) were less available screening techniques. Therefore, unavailability of the majority of the antenatal screening techniques is a likely consequence accounting for perinatal death occurrence in the country. This is contrary to the findings of Teresa (2015) who reported that congenital abnormalities account for 20-25% of perinatal deaths and the only option open to women who wished to know whether their fetus had Down syndrome was to have an invasive test (14). Even the available ones, pregnant women were not ready for the screening as reported by Martin et al (10) that prior to counselling on screening, over 56% of the 123 women were undecided about invasive testing.

Finally, the midwives’ level of knowledge of antenatal screening for congenital abnormality was not significantly associated with their readiness to practice antenatal screening and genetic testing. This could be as a result of high preparedness and eagerness to practice antenatal screening and genetic testing among the midwives if there is availability of equipment despite their insufficient knowledge of antenatal screening for congenital abnormality.

The study was limited to resourceful online limited materials and textbooks, and shifting nature of the nurse/midwife schedule of work.

Conclusion

In conclusion, the midwives had inadequate knowledge but are ready to practice antenatal screening and genetic testing for congenital abnormality despite their inadequate knowledge and little or non-attendance of seminar/workshop on antenatal screening and genetic testing for congenital abnormality due to obstacles such as lack of equipment, shortage of experience midwives and lack of information on genetic and antenatal screening.

In the light of this study results, it is recommended that: a) midwives should endeavour to improve their knowledge on antenatal screening and genetic testing for congenital abnormalities through attending both local and international training workshop/seminar. b) midwives should be encouraged to go for upgrading/advance studies to enhance their evidence based practice on antenatal screening and genetic testing for congenital abnormalities, c) government or employer of midwives should make available the equipment that will facilitate readiness to practice antenatal screening and genetic testing for congenital abnormalities in their facilities, d) government or employer of midwives should provide incentives to motivate attendance of training workshop / seminar for antenatal screening and genetic testing for congenital abnormalities.

Acknowledgements

We are gratefully acknowledged the apex matrons and midwives at Ifako- Ijaye, Isolo, Ikorodu Lagos Island Maternity and Ajeromi General Hospitals Lagos for their cooperation by providing useful information. Likewise, appreciation goes to Mrs. Beatrice Okoh, Mrs. Rahji, Mrs. Olugbade and Mr. Saheed for their suggestions at various points during the study.

Conflicts of interest

Authors declared no conflicts of interest.

  1. World Health Organization. The global report on Congenital abnormality.who.int/news-room/ fact-sheets, 2020.
  2. Helwick, C. Black People Overdosed with Schizophrenia Frequently Misunderstood by psychiatrists. National Medical Association, Annual Convention and Scientific Assembly. Medscape Medical News; 2012.
  3. Saul, RA. Genetics in Primary Care. 59th Annual Greenville Postgraduate Seminar, American Academy of Paediatrics.hsc.ghs.org/2015/04
  4. Ekwunife OH, Okoli CC, Ugwu JO, Modekwe VI and Ekwesianya AC. Congenital anomalies: Prospective study of pattern and associated risk factors in infants presenting to a tertiary hospital in Anambra State, South-east Nigeria. Niger Journal Paediatri. 2017; 44 (2): 76-80.
  5. Jeffrey S. , Sherman, E. Prenatal diagnostic testing. Merck manual home health handbook. 2008. Available at: m erck man ual.com/home/ wom en’s_h ealth_iss ues /genetic_disorders_detection/prenatal_diagnostic_testing/2019
  6. Mazer M, Romanelli Re-examining syphilis: an update on epidemiology, clinical manifestations, and management. Annuals of Pharmacotherapy. 2008; 42 (2): 226–236.
  7. Steer P. and Plumb, J. Group B streptococcal infection in pregnancy: Comprehended and conquered. Seminars in Fatal and Neonatal Medicine. 2011; 16 (5): 254–25
  8. Schroeder A, Jarvelin M. Coping of parent with physically and/or intellectually disabled child: Care health Development. 2013; 28 (1): 73 – 86.
  9. Edward K. and Msemo L. An audit of congenital malformations at national unit in Dar Es Salaam, Tanzania. Postgraduate Doctor Africa. 2008; 22: 16-19.
  10. Martin Hultom EK, Spelten ER, der Wal, JTG-v, Van den S. Midwives' views on appropriate antenatal counselling for congenital anomaly tests: Do they match clients' preferences? Midwifery. 2014; 30: 600–609
  11. Lea G, Heather S. A systematic review of nurses’ knowledge of genetics. Journal of Nursing Education and Practice. 2012; 2(3): 173-184.
  12. Brewer, J, Demers L & Musci T. Survey of US obstetrician opinions regarding NIPT use in general practice: implementation and barriers. The Journal of Maternal-Fetal & Neonatal Medicine. 2017; 30(15): 1793-1796. DOI: 10.1080/14767058. 2016; 1225035
  13. Yang L, Tan WC. Prenatal screening in the era of noninvasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice. BMC Pregnancy and Childbirth. 2020; 20(1): 1-8.
  14. Teresa Marino, MD. Prenatal Diagnosis for Congenital Malformations and Genetic Disorders. 2015; WebMD LLC.